ljc 10627 has been researched along with Tuberculosis, Drug-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, ZY; Li, P; Liu, S; Xu, SF; Yan, CX; Zhao, WJ; Zheng, MQ | 1 |
| Bell, DT; Chauhan, V; Kaushik, A; Kumar, P; Lamichhane, G; Stevens, RL; Xia, F | 1 |
2 other study(ies) available for ljc 10627 and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Activities of Biapenem against Mycobacterium tuberculosis in Macrophages and Mice.
Topics: Animals; Anti-Infective Agents; Cell Line; Drug Evaluation, Preclinical; Macrophages; Mice; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2019 |
Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; Cephalosporins; Clavulanic Acid; DNA, Intergenic; Gene Expression; Genetic Loci; Humans; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Protein Binding; Thienamycins; Tuberculosis, Multidrug-Resistant | 2017 |